Navigation Links
Antiviral Drugs May Be Useful For Easing Shingles Pain

According to a new study, oral and intravenous antiviral drug may be helpful in easing out shingles-related nerve pain//.

Shingles, which is caused by varicella-zoster virus, is a painful nervous disorder.

Foodconsumer.org reports that researchers at the University of Colorado and Health Sciences Center in Denver gave antiviral treatment to 12 men and three women with moderate to severe pain following shingles. The patients received 10 milligrams of the drug acyclovir intravenously every eight hours for 14 days. They then took three 1,000-milligram pills of the drug valacyclovir per day for one month.

The patients rated their pain on a scale of zero to 10 before they began treatment, then again after completing each therapy, and again one month after completing treatment.

As reported online this week by the journal Archives of Neurology, one month after treatment, eight (53 percent) of the patients reported significant reduction (two or more points) in their pain -- similar to the number of patients who reported similar improvements after day 15 and after day 45.

Five of the patients dropped out of the study early, three of them due to complications caused by the therapy. Most patients tolerated the treatment well, however, the researchers said.

'Although our study was small and without placebo control, the findings suggest a promising effect of antiviral treatment on postherpetic neuralgia [shingles nerve pain],' the study authors concluded.
'"/>




Page: 1

Related medicine news :

1. Roche Commits More Antiviral Pills To Asia For Bird Flu
2. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
3. Antiviral Coating On Bank Notes, Photocopiers Could Help Check Epidemics
4. Antiviral Drugs Curb Influenza Virus
5. Call For Bird Flu Antiviral Drugs To Be Shared
6. New Ribosome Finding Could Lead to Antiviral Therapies
7. Lean Protein Could Be Key to Obesity Drugs
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. Nasal Spray Could Take Drugs Direct to Brain.
10. Emphasis to ban Drugs ads by Doctors
11. Osteoporosis Drugs: right time to take-off
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: